Dilated cardiomyopathy and inclusion body myositis

Neurological Sciences

Volumn 33, Issue 2, 2012, Pages 367-370

  Ballo, Piercarlo ^a   Chiodi, Leandro ^a   Cameli, Matteo ^b   Malandrini, Alessandro ^b   Federico, Antonio ^b   Mondillo, Sergio ^b   Zuppiroli, Alfredo ^c  

^a SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c Local Health Unit   (Italy)

Author keywords

Dilated cardiomyopathy; Heart failure; Inclusion body myositis; Ventricular tachycardia

Indexed keywords

ANTIBODY; BENZODIAZEPINE DERIVATIVE; CREATINE KINASE; GADOLINIUM; SMI 31 ANTIBODY; TETRACOSACTIDE; UBIDECARENONE; UNCLASSIFIED DRUG; VENLAFAXINE;

AGED; ANTIBODY DETECTION; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CREATINE KINASE BLOOD LEVEL; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOKINESIA; IMMUNOHISTOCHEMISTRY; INCLUSION BODY MYOSITIS; MALE; MUSCLE BIOPSY; MUSCLE HYPERTROPHY; NEUROLOGIC EXAMINATION; ONSET AGE; QUADRICEPS FEMORIS MUSCLE; SYNCOPE; TRANSTHORACIC ECHOCARDIOGRAPHY; WEAKNESS;

AGED; BIOPSY; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; NEUROFILAMENT PROTEINS;

EID: 84863985913     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0766-2     Document Type: Article

References (12)

1. Needham M, Corbett A, Day T, Christiansen F, Fabian V, Mastaglia FL (2008) Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis. J Clin Neurosci 15:1350-1353
2. Grandis M, Gulli R, Cassandrini D, Gazzerro E, Benedetti L, Narciso E, Nobbio L, Bruno C, Minetti C, Bellone E, Reni L, Mancardi GL, Mandich P, Schenone A (2010) The spectrum of GNE mutations: allelic heterogeneity for a common phenotype. Neurol Sci 31:377-380
3. Needham M, James I, Corbett A et al (2008) Sporadic inclusion body myositis: phenotypic variability, influence of HLA-DR3 in a cohort of 57 Australian cases. J Neurol Neurosurg Psychiatry 79:1056-1060
4. Mastaglia FL, Zilko PJ (2003) Inflammatory myopathies: how to treat the difficult cases. J Clin Neurosci 10:99-101 (Pubitemid 35453259)
5. Cox FM, Delgado V, Verschuuren JJ, Ballieux BE, Bax JJ, Wintzen AR, Badrising UA (2010) The heart in sporadic inclusion body myositis: a study in 51 patients. J Neurol 257:447-451
6. Lundberg IE (2004) Cardiac involvement in autoimmune myositis and overlap syndromes. Handbook of systemic autoimmune diseases, vol 1. Elsevier, Amsterdam
7. Lundberg IE (2006) The heart in dermatomyositis and polymyositis. Rheumatology 45: iv18-iv21 (Pubitemid 44446758)
8. Krendel DA, Gilchrist JM, Bossen EH (1988) Distal vacuolar myopathy with complete heart block. Arch Neurol 45:698-699
9. Telerman-Toppet N, Bauherz G, Noël S (1991) Auriculo-ventricular block, distal myopathy with rimmed vacuoles, desmin storage. Clin Neuropathol 10:61-64
10. Askanas V, Engel WK, Alvarez RB, Frangione B, Ghiso J, Vidal R (2000) Inclusion body myositis, muscle blood vessel, cardiac amyloidosis, transthyretin Val122Ile allele. Ann Neurol 47:544-549 (Pubitemid 30194617)
11. Prutkin JM, Patton KK (2009) Ventricular tachycardia in a patient with inclusion-body myositis. Pacing Clin Electrophysiol 32:e36-e39
12. Utz W, Schmidt S, Schulz-Menger J, Luft F, Spuler S (2010) Cardiac involvement in sporadic inclusion-body myositis. Circulation 121:706-708